HighCape Partners, a venture fund established in 2013, operates in Baltimore, Maryland. With a focus on Series C and Series D stages, the fund concentrates on BioTech, Pharmaceuticals, and Healthcare industries. HighCape Partners, led by Partner Matt Zuga, has invested in 12 companies, including Cybrexa Therapeutics, and has successfully exited from 2. The firm specializes in supporting companies that commercialize high-margin life sciences products. For more details, visit their website at highcape.com.